MCRB
Price
$0.37
Change
-$0.03 (-7.50%)
Updated
Apr 17 closing price
Capitalization
64.51M
18 days until earnings call
MTVA
Price
$0.74
Change
+$0.01 (+1.37%)
Updated
Apr 17 closing price
Capitalization
6.4M
Ad is loading...

MCRB vs MTVA

Header iconMCRB vs MTVA Comparison
Open Charts MCRB vs MTVABanner chart's image
Seres Therapeutics
Price$0.37
Change-$0.03 (-7.50%)
Volume$2.66M
Capitalization64.51M
MetaVia
Price$0.74
Change+$0.01 (+1.37%)
Volume$598.93K
Capitalization6.4M
MCRB vs MTVA Comparison Chart
Loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCRB vs. MTVA commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCRB is a Hold and MTVA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (MCRB: $0.37 vs. MTVA: $0.74)
Brand notoriety: MCRB and MTVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MCRB: 257% vs. MTVA: 102%
Market capitalization -- MCRB: $64.51M vs. MTVA: $6.4M
MCRB [@Biotechnology] is valued at $64.51M. MTVA’s [@Biotechnology] market capitalization is $6.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCRB’s FA Score shows that 0 FA rating(s) are green whileMTVA’s FA Score has 0 green FA rating(s).

  • MCRB’s FA Score: 0 green, 5 red.
  • MTVA’s FA Score: 0 green, 5 red.
According to our system of comparison, MTVA is a better buy in the long-term than MCRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCRB’s TA Score shows that 4 TA indicator(s) are bullish while MTVA’s TA Score has 4 bullish TA indicator(s).

  • MCRB’s TA Score: 4 bullish, 4 bearish.
  • MTVA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MCRB is a better buy in the short-term than MTVA.

Price Growth

MCRB (@Biotechnology) experienced а -36.27% price change this week, while MTVA (@Biotechnology) price change was -46.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

MCRB is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCRB($64.5M) has a higher market cap than MTVA($6.4M). MCRB YTD gains are higher at: -55.475 vs. MTVA (-63.596). MTVA has higher annual earnings (EBITDA): -28.79M vs. MCRB (-120.3M). MCRB has more cash in the bank: 30.8M vs. MTVA (16M). MTVA has less debt than MCRB: MTVA (136K) vs MCRB (91.6M). MCRB (0) and MTVA (0) have equivalent revenues.
MCRBMTVAMCRB / MTVA
Capitalization64.5M6.4M1,008%
EBITDA-120.3M-28.79M418%
Gain YTD-55.475-63.59687%
P/E RatioN/AN/A-
Revenue00-
Total Cash30.8M16M193%
Total Debt91.6M136K67,353%
FUNDAMENTALS RATINGS
MCRB vs MTVA: Fundamental Ratings
MCRB
MTVA
OUTLOOK RATING
1..100
1250
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9698
P/E GROWTH RATING
1..100
10050
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTVA's Valuation (51) in the null industry is in the same range as MCRB (53) in the Biotechnology industry. This means that MTVA’s stock grew similarly to MCRB’s over the last 12 months.

MTVA's Profit vs Risk Rating (100) in the null industry is in the same range as MCRB (100) in the Biotechnology industry. This means that MTVA’s stock grew similarly to MCRB’s over the last 12 months.

MTVA's SMR Rating (100) in the null industry is in the same range as MCRB (100) in the Biotechnology industry. This means that MTVA’s stock grew similarly to MCRB’s over the last 12 months.

MCRB's Price Growth Rating (96) in the Biotechnology industry is in the same range as MTVA (98) in the null industry. This means that MCRB’s stock grew similarly to MTVA’s over the last 12 months.

MTVA's P/E Growth Rating (50) in the null industry is somewhat better than the same rating for MCRB (100) in the Biotechnology industry. This means that MTVA’s stock grew somewhat faster than MCRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCRBMTVA
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 6 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Ad is loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla
BTC.X84450.805000-444.945300
-0.52%
Bitcoin cryptocurrency

MCRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCRB has been loosely correlated with RIGL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MCRB jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCRB
1D Price
Change %
MCRB100%
-7.48%
RIGL - MCRB
38%
Loosely correlated
+2.18%
ATNM - MCRB
37%
Loosely correlated
-3.20%
OTLK - MCRB
32%
Poorly correlated
+5.84%
SPRB - MCRB
30%
Poorly correlated
-3.50%
MTVA - MCRB
29%
Poorly correlated
+0.64%
More

MTVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTVA has been closely correlated with SPRB. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTVA jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTVA
1D Price
Change %
MTVA100%
+0.64%
SPRB - MTVA
66%
Closely correlated
-3.50%
ETXPF - MTVA
51%
Loosely correlated
N/A
HOOK - MTVA
44%
Loosely correlated
N/A
LQDA - MTVA
44%
Loosely correlated
+0.29%
ARGX - MTVA
43%
Loosely correlated
+1.47%
More